Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: Selectivity of changes and possible correlation to pathological severity

Neurodegeneration

Volumn 5, Issue 2, 1996, Pages 169-176

  Haug, Lise Sofie ^c   Østvold, Anne Carine ^b   Cowburn, Richard F ^a   Garlind, Anita ^a   Winblad, Bengt ^a   Bogdanovich, Nenad ^a   Walaas, S Ivar ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c NONE

Author keywords

Alzheimer's disease; Ca2+ homeostasis; Calpain; IP3 receptor; Signal transduction

Indexed keywords

CALCIUM ION; CALPAIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMINASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PROTEIN; RADIOLIGAND; SYNAPTOPHYSIN;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BINDING SITE; BRAIN CORTEX; CALCIUM HOMEOSTASIS; CARBOXY TERMINAL SEQUENCE; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIGAND BINDING; MITOCHONDRION; NERVE CELL; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SECOND MESSENGER; TEMPORAL CORTEX;

EID: 0009713456     PISSN: 10558330     EISSN: None     Source Type: Journal    
DOI: 10.1006/neur.1996.0024     Document Type: Article

References (38)

1. Abraham CR, Selkow DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501
2. Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B (1987) Histopathological criteria for progressive dementia disorders: clinico-pathological correlation and classification by multi-variate data analysis. Acta Neuropathologica (Berl) 74:209-225
3. Beach TG, Walker R, McGeer EG (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2(6):420-436
4. Berridge MJ, Irvine RF (1993) Inositol trisphosphates and calcium signalling. Nature 36:315-325
5. Cataldo AM, Thayer CY, Bird ED, Wheelock TR, Nixon RA (1990) Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: Evidence for a neuronal origin. Brain Res 513:181-192
6. Dodd PR, Hambley JW, Cowburn RF, Hardy JA (1988) A comparison of methodologies for the study of functional transmitter biochemistry in human brain. J Neurochem 50:1333-1345
7. Duffy PE, Rapport M, Graf L (1980) Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 30:778-782
8. Ferris CD, Huganir RL, Supattapone S, Snyder SH (1989) Purified inositol 1,4,5 trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles. Nature 342:87-89
9. 3H] inositol 1,4,5-trisphosphate binding sites in human brain samples. Neurochem Int 24:73-80
10. 4 binding in Alzheimer's disease brain. Brain Res 681:160-166
11. Gibson GE, Peterson C (1987) Calcium and the aging nervous system. Neurobiol Aging 9:329-343
12. Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A (1985) The patients dying after long terminal phase have acidotic brains: implications for biochemical measurements on autopsy tissue. J Neural Transm 61:253-264
13. Kennedy MB (1989) Regulation of neuronal function by calcium. Trends Neurosci 12:417-420
14. 3H] inositol 1,4,5-trisphosphate binding in Huntington's disease. J Neurochem 56:1417-1422
15. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
16. 2+ channel. FEBS Lett 323:229-232
17. Masliah E, Terry RD, Alford M, De Teresa R, Hansen LA (1991) Cortical and subcortical patterns of synaptophysin like immunoreactivity in Alzheimer's disease. Am J Pathol 138:235-246
18. Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the standard Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analyt Biochem 87:206-210
19. McKahn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of the department of health and human services task force on Alzheimer's disease. Neurology 34:939-944
20. Mignery GA, Südhof TC (1990) The ligand binding site and transduction mechanism in the inositol 1,4,5-trisphosphate receptor. EMBO J 9:3893-3898
21. Mignery GA, Newton CL, Archer BT, Südhof TC (1990) Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. J Biol Chem 265:12679-12685
22. 2+: getting it up and keeping it up. Trends Neurosci 15:317-319
23. Miyawaki A, Furuichi T, Maeda N, Mikoshiba K (1990) Expressed cerebellar-type inositol 1,4,5-trisphosphate receptor P400 has calcium release activity in a fibroblast L cell line. Neuron 5:11-18.
24. Nilsson E, Alafuzoff I, Blennow K, Blomgren K, Hall CM, Janson I, Karlsson I, Wallin A, Gottfries CG, Karlsson JO (1990) Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue. Neurobiol Aging 11:425-431
25. Nixon RA, Saito KJ, Grynspan F, Griffin WR, Katayama S, Honda T, Mohan PS, Shea TB, Beermann M (1994) Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann NY Acad Sci 747:77-91
26. Pearson RCA, Powell TPS (1989) The neuroanatomy of Alzheimer's disease. Reviews in the Neurosciences 2:101-122
27. Ross CA, Danoff SK, Schell MJ, Snyder SH, Ullrich A (1992) Three additional inositol 1,4,5-trisphosphate receptors: Molecular cloning and differential localization in brain and peripheral tissues. Proc Natl Acad Sci USA 89:4265-4269
28. Schechter R, Yen SHC, Terry RD (1981) Fibrous astrocytes in senile dementia of the Alzheimer type. J Neuropathol Exp Neurol 40:95-101
29. Saito KJ, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer's disease: A potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90:2628-2632
30. Shimohama S, Suenaga T, Araki W, Yamaoaka Y, Shimizu K, Kimura J (1991) Presence of calpain II immunoreactivity in senile plaques in Alzheimer's disease. Brain Res 558:105-108
31. Supattapone S, Worley PF, Baraban JM, Snyder SH (1988) Solubilization, purification and characterization of an inositol trisphosphate receptor. J Biol Chem 263:1530-1534
32. Trump BF, Berezeky IK (1995) Calcium-mediated cell injury and cell death. FASEB J 9:219-228
33. Walaas SI, Nairn AC, Greengard P (1986) PCPP-260, a Purkinje cell-specific cyclic AMP-regulated membrane phosphoprotein of Mr 260,000. J Neurosci 6:954-961
34. 3H] inositol 1,4,5-trisphosphate binding in Huntington's disease. J Neurochem 56:1417-1422
35. Weeks G, Picciotto M, Nairn AC, Walaas SI, Greengard P (1988) Purification and characterization of PCPP-260: A Purkinje cell-enriched cyclic AMP regulated membrane phosphoprotein of Mr 260,000. Synapse 2:89-96
36. Wojcikiewicz RJH, Furuichi T, Nakade S, Mikoshiba K, Nahorski SR (1994) Muscarinic receptor activation down-regulates the type I inositol 1,4,5-trisphosphate receptor by accelerating its degradation. J Biol Chem 269:7963-7969
37. Yoshihara Y, Ueda H, Fujii N, Shide A, Yajima H, Satoh M. (1990) Purification of a novel type of calcium-activated neutral protease from rat brain. J Biol Chem 265:5809-5815
38. 3H] inositol 1,4,5-trisphosphate binding in Alzheimer's disease. Neurosci Letts 94:198-202